跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,939 条关于
“NaV1.8 inhibitor”
全部
19,939
临床试验
9,777
药物
4,081
机构
20
资讯
6,061
去年
Latigo Bio Doses First Participant in Phase 1 Trial of Non-Opioid Pain Drug LTG-305
2年前
Novel NaV1.8 Inhibitors Lead Wave of Non-Opioid Pain Treatments as Industry Tackles Opioid Crisis
2个月前
Latigo Biotherapeutics Files for IPO as Non-Opioid Pain Drug LTG-001 Advances to Late-Stage Testing
8年前
Eli Lilly Agrees to Acquire SiteOne Therapeutics for Up to $1 Billion in Non-Opioid Pain Therapy Deal
2年前
FDA Accepts Vertex's Suzetrigine NDA with Priority Review for Acute Pain
去年
Latigo Secures $150M Series B to Advance Non-Opioid Pain Medications Through Late-Stage Trials
去年
Eli Lilly Acquires SiteOne Therapeutics for Up to $1 Billion to Advance Non-Opioid Pain Treatment
去年
Vertex's Non-Opioid Suzetrigine Shows Promise in Phase 3 Acute Pain Trials
2年前
Vertex Pharmaceuticals Reports Strong Q1 2024 Performance, Advances Pipeline
去年
FDA Grants Fast Track Status to Latigo's Novel Non-Opioid Pain Treatment LTG-001
第 1 页,共 607 页
上一页
下一页